{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:18:54Z","timestamp":1790126334005,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI13C1527"],"award-info":[{"award-number":["HI13C1527"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016340","name":"Korean Society of Cardiology","doi-asserted-by":"publisher","award":["HI13C1527"],"award-info":[{"award-number":["HI13C1527"]}],"id":[{"id":"10.13039\/100016340","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.amjcard.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T13:16:52Z","timestamp":1441027012000},"page":"1502-1508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of Carvedilol Versus \u03b21-Selective \u03b2 Blockers (Bisoprolol, Metoprolol, and Nebivolol) in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"116","author":[{"given":"Guang-Won","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Young","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngkeun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Sang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.08.013_bib1","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2015.01.002","article-title":"Update on the guidelines for the management of ST-elevation myocardial infarction","volume":"115","author":"Levisman","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib2","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.08.013_bib3","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.cjca.2013.12.001","article-title":"Contemporary use of \u03b2-blockers: clinical relevance of subclassification","volume":"30","author":"Poirier","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.amjcard.2010.08.023","article-title":"Beta-blockers in hypertension","volume":"106","author":"Ram","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib5","doi-asserted-by":"crossref","first-page":"41L","DOI":"10.1016\/S0002-9149(97)00847-3","article-title":"Protective effects of carvedilol in the myocardium","volume":"80","author":"Feuerstein","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.08.013_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.amjcard.2013.10.020","article-title":"Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting","volume":"113","author":"DiNicolantonio","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/CIR.0b013e3182831a11","volume":"127","author":"Cannon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.08.013_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.amjcard.2015.08.013_bib10","first-page":"1","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Daniel","year":"2011","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.amjcard.2015.08.013_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.amjcard.2006.05.039","article-title":"Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction","volume":"98","author":"Kopecky","year":"2006","journal-title":"Am\u00a0J\u00a0Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.160.5.621","article-title":"Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials","volume":"160","author":"Bonet","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2015.08.013_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00392-006-0317-7","article-title":"Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention\u2014the PASSAT Study","volume":"95","author":"T\u00f6lg","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjcard.2015.01.545","article-title":"Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure","volume":"115","author":"Briasoulis","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000084584","article-title":"Comparison of the two \u03b2-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction: a single-centre, randomized study of 232 patients","volume":"103","author":"Jonsson","year":"2005","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2015.08.013_bib16","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalization for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2015.08.013_bib17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.amjcard.2014.09.019","article-title":"Current trend of acute myocardial infarction in Korea (from the Korea Acute Myocardial Infarction Registry from 2006 to 2013)","volume":"114","author":"Kook","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.amjcard.2013.08.013","article-title":"Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with\u00a0reduced versus preserved left ventricular ejection fractions","volume":"112","author":"Verbrugge","year":"2013","journal-title":"Am\u00a0J\u00a0Cardiol"},{"key":"10.1016\/j.amjcard.2015.08.013_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915018408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915018408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T01:56:37Z","timestamp":1617155797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915018408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0002914915018408"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.08.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725922046.793516000","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Carvedilol Versus \u03b21-Selective \u03b2 Blockers (Bisoprolol, Metoprolol, and Nebivolol) in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}